COMMONS

CDC's investments in low-income and fragile states examined

16 May 2019

The Sub-Committee takes evidence from the CDC group, the Department for International Development (DFID) on the review’s findings, whilst also questioning the Independent Commission for Aid Impact (ICAI) on their methodology and the Government’s response to ICAI's report on CDC's investments in low-income and fragile states.

Witnesses

Wednesday 22 May 2019, Committee Room 16, Palace of Westminster

At 9.50am:

Independent Commission for Aid Impact

  • Richard Gledhill, Lead Commissioner
  • Jonathan France, Team Leader

Department for International Development

  • Nick Dyer, Director General for Economic Development

CDC Group

  • Graham Wrigley, Chair
  • Nick O’Donohoe, Chief Executive Officer

Purpose of the Session

Following the publication of ICAI’s performance review looking at CDC Group’s investments in low-income and fragile states, this session provides an opportunity for Members to examine the progress that CDC has made redirecting its investments to low-income and fragile states; and supporting the Department for International Development’s economic development priorities.

Further information

Image: iStockphoto

Share this page